Robert E. Landry - Aug 31, 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Finance CFO
Signature
/s/** Robert E. Landry
Stock symbol
REGN
Transactions as of
Aug 31, 2021
Transactions value $
-$63,333
Form type
4
Date filed
9/1/2021, 04:05 PM
Previous filing
Aug 10, 2021
Next filing
Nov 18, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $556K +1K +3.86% $555.67 26.9K Aug 31, 2021 Direct
transaction REGN Common Stock Tax liability -$619K -917 -3.41% $675.03 26K Aug 31, 2021 Direct
holding REGN Common Stock 229 Aug 31, 2021 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -1K -20% $0.00 4K Aug 31, 2021 Common Stock 1K $555.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option award vests in four equal annual installments, commencing one year after the date of grant.